Source: Antimicrobial Agents and Chemotherapy. Unidade: IFSC
Subjects: STAPHYLOCOCCUS (ESTUDO), GENES, RNA, PROTEÍNAS
ABNT
CUI, Longzhu et al. An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, v. 54, n. 12, p. 5222-5233, 2010Tradução . . Disponível em: https://doi.org/10.1128/AAC.00437-10. Acesso em: 14 nov. 2024.APA
Cui, L., Isii, T., Fukuda, M., Ochiai, T., Neoh, H. -min, Camargo, I. L. B. da C., et al. (2010). An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 54( 12), 5222-5233. doi:10.1128/AAC.00437-10NLM
Cui L, Isii T, Fukuda M, Ochiai T, Neoh H-min, Camargo ILB da C, Watanabe Y, Shoji M, Hishinuma T, Hiramatsu K. An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus [Internet]. Antimicrobial Agents and Chemotherapy. 2010 ; 54( 12): 5222-5233.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1128/AAC.00437-10Vancouver
Cui L, Isii T, Fukuda M, Ochiai T, Neoh H-min, Camargo ILB da C, Watanabe Y, Shoji M, Hishinuma T, Hiramatsu K. An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus [Internet]. Antimicrobial Agents and Chemotherapy. 2010 ; 54( 12): 5222-5233.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1128/AAC.00437-10